Kura Oncology KURA Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kura Oncology's operating lease liabilities?
- Kura Oncology (KURA) reported operating lease liabilities of $13.24M in Q1 2026.
- How has Kura Oncology's operating lease liabilities changed year-over-year?
- Kura Oncology's operating lease liabilities increased by 68.1% year-over-year, from $7.88M to $13.24M.
- What is the long-term trend for Kura Oncology's operating lease liabilities?
- Over 5 years (2020 to 2025), Kura Oncology's operating lease liabilities has grown at a 10.9% compound annual growth rate (CAGR), from $5.64M to $9.47M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.